Австралия - английски - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefalotin sodium, quantity: 1.058 g (equivalent: cefalotin, qty 1 g) - injection, powder for - excipient ingredients: sodium bicarbonate - indications: cephalothin sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. culture and susceptibility studies should be performed. however, therapy may be instituted before results of susceptibility studies are obtained (see pharmacology: microbiology). respiratory tract: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, klebsiella, and h. influenzae. skin and soft tissue: infections, including peritonitis, caused by staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, e.coli, pr. mirabilis and klebsiella. genitourinary tract: infections caused by e. coli, pr. mirabilis and klebsiella. septicaemia, including endocarditis: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, s. viridans, e. coli, pr. mirabilis and klebsiella. bone and joint: infection caused by staphylococci (penicillinase and non-penicillinase producing). prophylactically in vaginal hysterectomy, head and neck surgery, insertion of prosthetic heart valves, and prosthetic arthroplasty. cephalothin is not recommended for gastrointestinal procedures or other sites where anaerobic organisms such as bacteriodes tend to prevail. dosage is required pre-, intra-and postoperatively (i.e perioperatively, see dosage and administration). if signs of postoperative infection develop, specimens should be cultured to identify the causative organism so that appropriate therapy can be instituted. note: if the susceptibility tests show that the causative organism is resistant to cephalothin, other appropriate antibiotic therapy should be instituted.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefalotin sodium -

Малта - английски - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - heparin sodium - solution for injection concentrate for solution for infusion - heparin sodium 1000 iu/ml - antithrombotic agents

Австралия - английски - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cefalotin -

Ирландия - английски - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - sodium chloride - solvent for parenteral use - 0.9 %v/w - sodium chloride

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - heparin sodium - solution for injection - 1000unit/1ml

Ирландия - английски - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Ирландия - английски - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Ирландия - английски - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin

Ирландия - английски - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 25,000 international unit(s)/millilitre - heparin group; heparin